AltTox.org

Non-animal Methods for Toxicity Testing

AltTox Forum

 
September 01, 2015, 01:57:26 am *
Welcome, Guest. Please login or register.

Login with username, password and session length
Forgot your password?
 
Pages: [1]   Go Down
  Print  
Author Topic: FDA Releases Draft Guidance on Use of Nanotechnology  (Read 2025 times)
Sherry Ward
AltTox
Full Member
***
Offline Offline

Posts: 242



« on: June 09, 2011, 04:25:42 pm »

"The U.S. Food and Drug Administration today [June 9, 2010] released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology."

FDA Press Release: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm258377.htm

Draft Guidance: "Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology" available at:http://www.fda.gov/RegulatoryInformation/Guidances/ucm257698.htm

Comments on the FDA draft document can be submitted within 60 days of its publication in the Federal Register.

Release of the FDA guidance document was coordinated to occur with a Memorandum issued by the Office of Science and Technology Policy, Office of Management and Budget, and the United States Trade Representative, “Policy Principles for the U.S. Decision-Making Concerning Regulation and Oversight of Applications of Nanotechnology and Nanomaterials,” available at: http://www.whitehouse.gov/sites/default/files/omb/inforeg/for-agencies/nanotechnology-regulation-and-oversight-principles.pdf
8: Undefined index: alttoxdisclaimer
File: /usr/www/users/alttox/Themes/AltTox_Template/Display.template.php (main sub template - eval?)
Line: 434